<DOC>
	<DOC>NCT02994615</DOC>
	<brief_summary>Patients with hypertrophic cardiomyopathy are being compared to a control group. IMR will be assessed with a pressure wire. Clinical f/u at 3 months and 6 months and a 48 hour holter monitor.</brief_summary>
	<brief_title>Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
	<criteria>Age 1880 Already have an indication for coronary angiography Previous diagnosis of hypertrophic cardiomyopathy (unless control) Fractional flow reserve found to be significant (FFR &lt; 0.8) Already have a condition associated with or likely to be associated with an elevated IMR (diabetes, cardiac syndrome X, takotsubo cardiomyopathy, hypertensive cardiomyopathy, severe aortic stenosis, STEMI)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Index of Microvascular Resistance</keyword>
	<keyword>Microvascular dysfunction</keyword>
</DOC>